Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

NCT02270957 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Abatacept
OTHER: Placebo

Sponsor

Oklahoma Medical Research Foundation

Collaborators

[object Object]